"Academic Incubator" to develop new medicines of value
01 September 2008GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Research
GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Many UK manufacturers have transferred their production to low-cost regions to reduce costs. But a new study has discovered that these savings are not as...
A magnificent new collection at the University Library makes Cambridge a major international centre for Montaigne scholarship.
Recent funding will enable collaboration between classicists and museum curators, and shape a major re-display of Greek and Roman art and archaeology.
Judge Business School have launched a major new forum devoted to excellence in global human resource management – the Centre for International Human Resource Management...
Why does one violin sound different to another? Investigating this question has brought together researchers from music, engineering, experimental psychology and computer science.
Terrorist groups, guerrilla movements, drug smuggling: Mette Eilstrup-Sangiovanni asks whether examining the structural weaknesses of illicit networks holds the key to combating them.
Current estimates suggest that a language dies every two weeks. Here, Geoffrey Khan describes the documentation of a group of dialects before they are lost...
A unique model of industrial-academic partnership is demonstrating how UK R&D can stay ahead of the game in a rapidly moving electronics market.
Local authorities are failing to consider women's needs in their planning schemes, more than a year after legislation designed to stop the problem was introduced,...